Education
About Us
Working with TipRanks
Follow Us
Emma Reeve Insider Profile
11 Followers
Emma Reeve, Corp. VP & Interim CFO at Parexel, holds 6.67K shares in PTC Therapeutics (Ticker: PTCT), holds 6.12K shares in Parexel (Ticker: PRXL), holds 0.00 shares in Constellation Pharmaceuticals (Ticker: CNST).
Emma Reeve Parexel (PRXL)Corp. VP & Interim CFO
Parexel (PRXL)
Corp. VP & Interim CFO
Not Ranked
Emma Reeve has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Emma Reeve holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Emma Reeve
Emma Reeve's Trading History
Parexel
Dec 09, 2016
―
Uninformative Buy
―
$539.05K
PTC Therapeutics
Oct 31, 2025
Director
Uninformative Buy
457.20K
$452.82K
Constellation Pharmaceuticals
―
―
―
$0.00
Editas Medicine
―
Director
―
―
Whitehawk Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Emma Reeve's performance on stock
You May Also Like
Emma Reeve insider profile FAQ
What is the percentage of profitable transactions made by Emma Reeve?
The percentage of profitable transactions made by Emma Reeve is ―.
What is the average return per transaction made by Emma Reeve?
The average return per transaction made by Emma Reeve is ―.
What stocks does Emma Reeve hold?
Emma Reeve holds: PRXL, PTCT, CNST, EDIT, WHWK stocks.
What was Emma Reeve’s latest transaction?
Emma Reeve latest transaction was an Uninformative Buy of $457.20K.
What was Emma Reeve's most profitable transaction?
Emma Reeve’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Emma Reeve's role in Parexel?
Emma Reeve's role in Parexel is Corp. VP & Interim CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.